RHYTHM PHARMACEUTICALS, INC. Accrued Liabilities, Current
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Accrued Liabilities, Current of $83.86 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-02-26
- 2025-12-31: Accrued Liabilities, Current $83.86M.
- 2025-03-31: Accrued Liabilities, Current $59.31M.
- 2024-12-31: Accrued Liabilities, Current $62.66M.
- 2024-09-30: Accrued Liabilities, Current $54.80M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-12-31 | $83.86M 10-K · filed 2026-02-26 |
| 2025-03-31 | $59.31M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $62.66M 10-K · filed 2026-02-26 |
| 2024-09-30 | $54.80M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $48.08M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $44.53M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $48.26M 10-K · filed 2025-02-28 |
| 2023-09-30 | $44.27M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $35.71M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $30.55M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $32.89M 10-K · filed 2024-02-29 |
| 2022-09-30 | $25.74M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $35.60M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $25.20M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $30.08M 10-K · filed 2023-03-01 |
| 2021-09-30 | $18.27M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $11.88M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $7.15M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $12.56M 10-K · filed 2022-03-01 |
| 2020-09-30 | $11.54M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $9.64M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $11.28M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $13.53M 10-K · filed 2021-03-01 |
| 2019-09-30 | $17.00M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $19.15M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $8.37M 10-Q · filed 2019-05-03 |
| 2018-12-31 | $5.94M 10-K · filed 2020-03-02 |
| 2018-09-30 | $7.59M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $3.85M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $3.04M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $4.21M 10-K · filed 2019-03-08 |
| 2017-09-30 | $3.11M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $2.65M 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |